Perspectives in Vascular Surgery and Endovascular Therapy

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Register here to gain access to SAGE's 500+ Journals Online

Click here to browse AJSM online!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ayerdi, J.
Right arrow Articles by Hodgson, K. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ayerdi, J.
Right arrow Articles by Hodgson, K. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Perspectives in Vascular Surgery and Endovascular Therapy, Vol. 16, No. 1, 25-38 (2004)
DOI: 10.1177/153100350401600108

Balloon Angioplasty and Stenting for Renovascular Occlusive Disease

Juan Ayerdi, MD

Wake Forest University School of Medicine, Winston-Salem, North Carolina

Kim J. Hodgson, MD

Section of Vascular Surgery, Southern Illinois University School of Medicine, PO Box 19638, Springfield, IL 62794; khodgson{at}siumed.edu

Over the past two decades, percutaneous transluminal renal angioplasty has been performed with increasing frequency and for more liberal indications, even though only a handful of prospective clinical trials have been reported and indications for intervention and long-term effectiveness have not been well established. This procedure continues to rapidly evolve, driven by a high physician, public, and industry demand for a less morbid minimally invasive approach to renovascular occlusive disease. Although percutaneous transluminal renal angioplasty procedures are traditionally considered "low risk", complications and failures are not innocuous in terms of clinical consequences. We review the fundamental aspects of renal angioplasty and stenting, with emphasis on the technical details, caveats to avoid complications, and a brief review of our experience with percutaneous transluminal renal angioplasty at Southern Illinois University School of Medicine.

Key Words: Renovascular hypertension • ischemic nephropathy • percutaneous angioplasty • renovascular disease • percutaneous renal angioplasty


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?